-
Je něco špatně v tomto záznamu ?
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
D. Riemann, CA. Espie, E. Altena, ES. Arnardottir, C. Baglioni, CLA. Bassetti, C. Bastien, N. Berzina, B. Bjorvatn, D. Dikeos, L. Dolenc Groselj, JG. Ellis, D. Garcia-Borreguero, PA. Geoffroy, M. Gjerstad, M. Gonçalves, E. Hertenstein, K....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
PubMed
38016484
DOI
10.1111/jsr.14035
Knihovny.cz E-zdroje
- MeSH
- antidepresiva terapeutické užití MeSH
- benzodiazepiny terapeutické užití MeSH
- dospělí MeSH
- lidé MeSH
- melatonin * terapeutické užití farmakologie MeSH
- poruchy iniciace a udržování spánku * terapie farmakoterapie MeSH
- spánek MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Progress in the field of insomnia since 2017 necessitated this update of the European Insomnia Guideline. Recommendations for the diagnostic procedure for insomnia and its comorbidities are: clinical interview (encompassing sleep and medical history); the use of sleep questionnaires and diaries (and physical examination and additional measures where indicated) (A). Actigraphy is not recommended for the routine evaluation of insomnia (C), but may be useful for differential-diagnostic purposes (A). Polysomnography should be used to evaluate other sleep disorders if suspected (i.e. periodic limb movement disorder, sleep-related breathing disorders, etc.), treatment-resistant insomnia (A) and for other indications (B). Cognitive-behavioural therapy for insomnia is recommended as the first-line treatment for chronic insomnia in adults of any age (including patients with comorbidities), either applied in-person or digitally (A). When cognitive-behavioural therapy for insomnia is not sufficiently effective, a pharmacological intervention can be offered (A). Benzodiazepines (A), benzodiazepine receptor agonists (A), daridorexant (A) and low-dose sedating antidepressants (B) can be used for the short-term treatment of insomnia (≤ 4 weeks). Longer-term treatment with these substances may be initiated in some cases, considering advantages and disadvantages (B). Orexin receptor antagonists can be used for periods of up to 3 months or longer in some cases (A). Prolonged-release melatonin can be used for up to 3 months in patients ≥ 55 years (B). Antihistaminergic drugs, antipsychotics, fast-release melatonin, ramelteon and phytotherapeutics are not recommended for insomnia treatment (A). Light therapy and exercise interventions may be useful as adjunct therapies to cognitive-behavioural therapy for insomnia (B).
Center for Basics in NeuroModulation Faculty of Medicine University of Freiburg Freiburg Germany
Centre for Cognitive Neurosciences University of Salzburg Salzburg Austria
Centro de Medicina de Sono Hospital Cuf Porto Portugal
Department of Clinical Medicine University of Copenhagen Kobenhavn Denmark
Department of Clinical Psychology University of Amsterdam Amsterdam The Netherlands
Department of Education and Psychology University of Aveiro Aveiro Portugal
Department of Global Public Health and Primary Care University of Bergen Bergen Norway
Department of Internal Medicine and Pediatrics Ghent University Ghent Belgium
Department of Neurology and Neurosurgery Armenian National Institute of Health Yerevan Armenia
Department of Neurology Inselspital University of Bern Berne Switzerland
Department of Psychiatry Paris Cite University Paris France
Department of Psychiatry University Hospital Geneve Geneve Switzerland
Division of Psychology Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden
East Viru Central Hospital Kohtla Järve Estonia
École de Psychologie Université Laval Québec Québec Canada
Finnish Institute of Occupational Health Helsinki Finland
Functional Neurology Institute of Neurology and Neurosurgery Chisinau Moldova
Human Sciences Department University of Rome Guglielmo Marconi Rome Rome Italy
Institute for Consciousness and Dream Research Vienna Austria
Institute of Clinical Neurophysiology University Medical Center Ljubljana Ljubljana Slovenia
Institute of Epidemiology and Social Medicine University of Münster Münster Germany
Landspitali The National University Hospital of Iceland Reykjavik Iceland
Northumbria Sleep Research Laboratory Northumbria University Newcastle UK
Psychiatric Practice Riga Latvia
Public Health and Welfare Finnish Institute for Health and Welfare Helsinki Finland
Reykjavik University Sleep Institute School of Technology Reykjavik University Reykjavik Iceland
Sleep Research Institute Madrid Spain
Stavanger University Hospital Stavanger Norway
The Cheryl Spencer Institute of Nursing Research University of Haifa Haifa Israel
Université de Bordeaux Bordeaux France
Université Paris Cité APHP Hôtel Dieu de Paris Centre du Sommeil et de la Vigilance Paris France
University Hospital of Psychiatry and Psychotherapy University of Bern Bern Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000336
- 003
- CZ-PrNML
- 005
- 20240213093121.0
- 007
- ta
- 008
- 240109s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jsr.14035 $2 doi
- 035 __
- $a (PubMed)38016484
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Riemann, Dieter $u Department of Clinical Psychology and Psychophysiology, Centre for Mental Health (Department), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $u Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany $1 https://orcid.org/0000000219686220 $7 nlk20030145803
- 245 14
- $a The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 / $c D. Riemann, CA. Espie, E. Altena, ES. Arnardottir, C. Baglioni, CLA. Bassetti, C. Bastien, N. Berzina, B. Bjorvatn, D. Dikeos, L. Dolenc Groselj, JG. Ellis, D. Garcia-Borreguero, PA. Geoffroy, M. Gjerstad, M. Gonçalves, E. Hertenstein, K. Hoedlmoser, T. Hion, B. Holzinger, K. Janku, M. Jansson-Fröjmark, H. Järnefelt, S. Jernelöv, PJ. Jennum, S. Khachatryan, L. Krone, SD. Kyle, J. Lancee, D. Leger, A. Lupusor, DR. Marques, C. Nissen, L. Palagini, T. Paunio, L. Perogamvros, D. Pevernagie, M. Schabus, T. Shochat, A. Szentkiralyi, E. Van Someren, A. van Straten, A. Wichniak, J. Verbraecken, K. Spiegelhalder
- 520 9_
- $a Progress in the field of insomnia since 2017 necessitated this update of the European Insomnia Guideline. Recommendations for the diagnostic procedure for insomnia and its comorbidities are: clinical interview (encompassing sleep and medical history); the use of sleep questionnaires and diaries (and physical examination and additional measures where indicated) (A). Actigraphy is not recommended for the routine evaluation of insomnia (C), but may be useful for differential-diagnostic purposes (A). Polysomnography should be used to evaluate other sleep disorders if suspected (i.e. periodic limb movement disorder, sleep-related breathing disorders, etc.), treatment-resistant insomnia (A) and for other indications (B). Cognitive-behavioural therapy for insomnia is recommended as the first-line treatment for chronic insomnia in adults of any age (including patients with comorbidities), either applied in-person or digitally (A). When cognitive-behavioural therapy for insomnia is not sufficiently effective, a pharmacological intervention can be offered (A). Benzodiazepines (A), benzodiazepine receptor agonists (A), daridorexant (A) and low-dose sedating antidepressants (B) can be used for the short-term treatment of insomnia (≤ 4 weeks). Longer-term treatment with these substances may be initiated in some cases, considering advantages and disadvantages (B). Orexin receptor antagonists can be used for periods of up to 3 months or longer in some cases (A). Prolonged-release melatonin can be used for up to 3 months in patients ≥ 55 years (B). Antihistaminergic drugs, antipsychotics, fast-release melatonin, ramelteon and phytotherapeutics are not recommended for insomnia treatment (A). Light therapy and exercise interventions may be useful as adjunct therapies to cognitive-behavioural therapy for insomnia (B).
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a poruchy iniciace a udržování spánku $x terapie $x farmakoterapie $7 D007319
- 650 12
- $a melatonin $x terapeutické užití $x farmakologie $7 D008550
- 650 _2
- $a spánek $7 D012890
- 650 _2
- $a benzodiazepiny $x terapeutické užití $7 D001569
- 650 _2
- $a antidepresiva $x terapeutické užití $7 D000928
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Espie, Colin A $u Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neuroscience at the University of Oxford, Oxford, UK $1 https://orcid.org/0000000212948734
- 700 1_
- $a Altena, Ellemarije $u Université de Bordeaux, Bordeaux, France
- 700 1_
- $a Arnardottir, Erna Sif $u Reykjavik University Sleep Institute, School of Technology, Reykjavik University, Reykjavik, Iceland $u Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland $1 https://orcid.org/0000000308773529
- 700 1_
- $a Baglioni, Chiara $u Human Sciences Department, University of Rome Guglielmo Marconi Rome, Rome, Italy $1 https://orcid.org/0000000331507755
- 700 1_
- $a Bassetti, Claudio L A $u Department of Neurology, Inselspital, University of Bern, Berne, Switzerland
- 700 1_
- $a Bastien, Celyne $u École de Psychologie, Université Laval, Québec, Québec, Canada
- 700 1_
- $a Berzina, Natalija $u Psychiatric Practice, Riga, Latvia
- 700 1_
- $a Bjorvatn, Bjørn $u Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
- 700 1_
- $a Dikeos, Dimitris $u First Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Dolenc Groselj, Leja $u Institute of Clinical Neurophysiology, University Medical Center Ljubljana, Ljubljana, Slovenia $1 https://orcid.org/000000028350951X
- 700 1_
- $a Ellis, Jason G $u Northumbria Sleep Research Laboratory, Northumbria University, Newcastle, UK $1 https://orcid.org/000000028496520X $7 ola2018997622
- 700 1_
- $a Garcia-Borreguero, Diego $u Sleep Research Institute, Madrid, Spain
- 700 1_
- $a Geoffroy, Pierre A $u Department of Psychiatry, Paris Cite University, Paris, France $1 https://orcid.org/000000019121209X
- 700 1_
- $a Gjerstad, Michaela $u Stavanger University Hospital, Stavanger, Norway
- 700 1_
- $a Gonçalves, Marta $u Centro de Medicina de Sono, Hospital Cuf, Porto, Portugal
- 700 1_
- $a Hertenstein, Elisabeth $u University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland
- 700 1_
- $a Hoedlmoser, Kerstin $u Centre for Cognitive Neurosciences, University of Salzburg, Salzburg, Austria
- 700 1_
- $a Hion, Tuuliki $u East-Viru Central Hospital, Kohtla-Järve, Estonia
- 700 1_
- $a Holzinger, Brigitte $u Institute for Consciousness and Dream Research, Vienna, Austria
- 700 1_
- $a Janku, Karolina $u Center for Sleep and Chronobiology Research, National Institute of Mental Health, Klecany, Czech Republic $1 https://orcid.org/0000000268046967
- 700 1_
- $a Jansson-Fröjmark, Markus $u Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden $u Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden and Stockholm Health Care Services, Stockholm, Sweden $1 https://orcid.org/0000000320591621
- 700 1_
- $a Järnefelt, Heli $u Finnish Institute of Occupational Health, Helsinki, Finland
- 700 1_
- $a Jernelöv, Susanna $u Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden $u Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden and Stockholm Health Care Services, Stockholm, Sweden $1 https://orcid.org/0000000206338104
- 700 1_
- $a Jennum, Poul Jørgen $u Department of Clinical Medicine, University of Copenhagen, Kobenhavn, Denmark
- 700 1_
- $a Khachatryan, Samson $u Department of Neurology and Neurosurgery, Armenian National Institute of Health, Yerevan, Armenia $1 https://orcid.org/0000000230982135
- 700 1_
- $a Krone, Lukas $u Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neuroscience at the University of Oxford, Oxford, UK $u Department of Neurology, Inselspital, University of Bern, Berne, Switzerland $u University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland $1 https://orcid.org/0000000255357221
- 700 1_
- $a Kyle, Simon D $u Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neuroscience at the University of Oxford, Oxford, UK
- 700 1_
- $a Lancee, Jaap $u Department of Clinical Psychology, University of Amsterdam, Amsterdam, The Netherlands $1 https://orcid.org/0000000277225780
- 700 1_
- $a Leger, Damien $u Université Paris Cité, APHP, Hôtel Dieu de Paris, Centre du Sommeil et de la Vigilance, Paris, France $1 https://orcid.org/000000031168480X
- 700 1_
- $a Lupusor, Adrian $u Functional Neurology, Institute of Neurology and Neurosurgery, Chisinau, Moldova
- 700 1_
- $a Marques, Daniel Ruivo $u Department of Education and Psychology, University of Aveiro, Aveiro, Portugal $u CINEICC - Center for Research in Neuropsychology and Cognitive Behavioral Intervention, Faculty of Psychology and Educational Sciences, University of Coimbra, Coimbra, Portugal $1 https://orcid.org/0000000337290120
- 700 1_
- $a Nissen, Christoph $u Department of Psychiatry, University Hospital Geneve, Geneve, Switzerland $1 https://orcid.org/0000000198090275
- 700 1_
- $a Palagini, Laura $u Psychiatry Unit, Department of Clinical and Experimental Medicine, School of Medicine, University of Pisa, Pisa, Italy $1 https://orcid.org/000000031676629X
- 700 1_
- $a Paunio, Tiina $u Department of Psychiatry and SleepWell Research Program, Faculty of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland
- 700 1_
- $a Perogamvros, Lampros $u Department of Psychiatry, University Hospital Geneve, Geneve, Switzerland
- 700 1_
- $a Pevernagie, Dirk $u Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium $1 https://orcid.org/0000000273728583
- 700 1_
- $a Schabus, Manuel $u Centre for Cognitive Neurosciences, University of Salzburg, Salzburg, Austria
- 700 1_
- $a Shochat, Tamar $u The Cheryl Spencer Institute of Nursing Research, University of Haifa, Haifa, Israel $1 https://orcid.org/0000000243713567
- 700 1_
- $a Szentkiralyi, Andras $u Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany
- 700 1_
- $a Van Someren, Eus $u Department of Sleep and Cognition, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands $u Departments of Integrative Neurophysiology and Psychiatry, Center for Neurogenomics and Cognitive Research, Amsterdam UMC, Amsterdam Neuroscience, VU University, Amsterdam, The Netherlands $1 https://orcid.org/0000000299708791
- 700 1_
- $a van Straten, Annemieke $u Department of Clinical, Neuro- and Developmental Psychology & Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands $1 https://orcid.org/0000000168752215
- 700 1_
- $a Wichniak, Adam $u Sleep Medicine Center and Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
- 700 1_
- $a Verbraecken, Johan $u Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Antwerp, Belgium
- 700 1_
- $a Spiegelhalder, Kai $u Department of Clinical Psychology and Psychophysiology, Centre for Mental Health (Department), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany $1 https://orcid.org/0000000241333464
- 773 0_
- $w MED00002940 $t Journal of sleep research $x 1365-2869 $g Roč. 32, č. 6 (2023), s. e14035
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38016484 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093118 $b ABA008
- 999 __
- $a ok $b bmc $g 2049166 $s 1210030
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 32 $c 6 $d e14035 $e - $i 1365-2869 $m Journal of sleep research $n J Sleep Res $x MED00002940
- LZP __
- $a Pubmed-20240109